A new noninvasive test to detect mitochondrial dysfunction of skeletal muscles in progressive supranuclear palsy

Annals of the New York Academy of Sciences

Volumn 1042, Issue , 2005, Pages 76-81

  Chang, Yung Yee ^a   Lee, Chiang Hsuan ^a   Lan, Min Yu ^a   Wu, Hsiu Shan ^a   Chang, Chiung Chih ^a   Liu, Jia Shou ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Mitochondria; Parkinsonism; Progressive supranuclear palsy; Single photon emission computed tomography (SPECT); Skeletal muscle; Technetium 99m methoxyisobutyl isonitrile (99mTc sestamibi)

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; BIOENERGY; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIAGNOSTIC PROCEDURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG UPTAKE; FEMALE; HUMAN; MALE; MUSCLE MITOCHONDRION; PARKINSONISM; PATHOGENESIS; PROGRESSIVE SUPRANUCLEAR PALSY; QUADRICEPS FEMORIS MUSCLE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 22044435570     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1338.046     Document Type: Conference Paper

References (19)

1. LITVAN, I., Y. AGID, D. CALNE, et al. 1996. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47: 1-9.
2. BURN, D.J. & A.J. LEES. 2002. Progressive supranuclear palsy: where are we now? Lancet Neurol. 1: 359-369.
3. SPILLANTINI, M.G. & M. GOEDERT. 1998. Tau protein pathology in neurodegenerative diseases. Trends Neurosci. 21: 428-433.
4. ALBERS, D.S. & S.J. AUGOOD. 2001. New insights into progressive supranuclear palsy. Trends Neurosci. 24: 347-353.
5. ALBERS, D.S. & M.F. BEAL. 2002. Mitochondrial dysfunction in progressive supranuclear palsy. Neurochem. Int. 40: 559-564.
6. PARK, L.C., D.S. ALBERS, H. XU, et al. 2001. Mitochondrial impairment in the cerebellum of the patients with progressive supranuclear palsy. J. Neurosci. Res. 66: 1028-1034.
7. ALBERS, D.S., S.G. AUGOOD, L.C. PARK, et al. 2000. Frontal lobe dysfunction in progressive supranuclear palsy: evidence for oxidative stress and mitochondrial impairment. J. Neurochem. 74: 878-881.
8. SWERDLOW, R.H., L.I. GOLBE, J.K. PARKS, et al. 2000. Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy. J. Neurochem. 75: 1681-1684.
9. DI MONTE, D.A., Y. HARATI, J. JANKOVIC, et al. 1994. Muscle mitochondrial ATP production in progressive supranuclear palsy. J. Neurochem. 62: 1631-1634.
10. MARTINELLI, P., C. SCAGLIONE, R. LODI, et al. 2000. Deficit of brain and skeletal muscle bioenergetics in progressive supranuclear palsy shown in vivo by phosphorus magnetic resonance spectroscopy. Mov. Disord. 15: 889-893.
11. WACKERS, F.J., D.S. HERMAN, J. MADDAHI, et al. 1989. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J. Nucl. Med. 30: 301-311.
12. OKADA, R.D., D. GLOVER, T. GAFFNEY & S. WILLIAMS. 1988. Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. Circulation 77: 491-498.
13. BEANLANDS, R.S., F. DAWOOD, W.H. WEN, et al. 1990. Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability? Circulation 82: 1802-1814.
14. MAUBLANT, J.C., P. GACHON & N. MOINS. 1988. Hexakis (2-methoxy isobutylisonitrile) technetium-99m and thallium-201 chloride: uptake and release in cultured myocardial cells. J. Nucl. Med. 29: 48-54.
15. SARIKAYA, A., S. SEN, T.F. CERMIK, et al. 2000. Evaluation of skeletal muscle metabolism and response to erythropoietin treatment in patients with chronic renal failure using 99Tcm-sestamibi leg scintigraphy. Nucl. Med. Commun. 21: 83-87.
16. LUPATTELLI, G., B. PALUMBO & H. SINZINGER. 2001. Stalin induced myopathy does not show up in MIBI scintigraphy. Nucl. Med. Commun. 22: 575-578.
17. SCOPINARO, F., C. MANNI, A. MICCHELI, et al. 1996. Muscular uptake of Tc-99m MIBI and TI-201 in Duchenne muscular dystrophy. Clin. Nucl. Med. 21: 792-796.
18. PIWNICA-WORMS, D., J.F. KRONAUGE & M.L. CHIU. 1990. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium (I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. Circulation 82: 1826-1838.
19. CRANE, P., R. LALIBERTE, S. HEMINWAY, et al. 1993. Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention. Eur. J. Nucl. Med. 20: 20-25.